Colgate-Palmolive India Share Price Target at Rs 2,500: Motilal Oswal
Motilal Oswal reaffirmed a BUY rating for Colgate-Palmolive India, setting a price target of Rs 2,500, a 27% upside from the current price of Rs 1,965. The brokerage values the company at 40 times its estimated March 2027 earnings, citing strong growth pillars, premiumisation, and high margins. Colgate's strategy focuses on consumption creation and scientific premiumisation, with a 52-week range of Rs 1,782–2,505.
How this was made
The 30-second read
Why it matters
The new target could attract fresh buying, raising the stock toward the upper end of its 52‑week range.
Market read
Analyst upgrade with a sizable upside target provides a clear trading catalyst for CL.
What to watch
Potential supply chain constraints and price sensitivity in rural markets.
Background
Analyst meet update from Motilal Oswal presenting a revised valuation for Colgate-Palmolive India.
Ticker impact
Motilal Oswal reiterates BUY on Colgate-Palmolive with a new Rs 2,500 price target, 27% upside.
Potential 5-10% upside in the near term as investors adjust valuations.
Target is 27% above current price with a strong earnings multiple, indicating significant upside perception.
Market effects
May lift sentiment for consumer staples and oral care stocks in India.
Positive for Indian consumer discretionary sector.
Limited, primarily affects CL and Indian market participants.
Counterpoint
Target may be overly optimistic given modest near-term growth and competition.
Key entities
- CompanyColgate-Palmolive
Consumer goods company focusing on oral care.
- Research FirmMotilar Oswal
Brokerage providing the target price and buy recommendation.
